Postdoctoral Research Associate
Research Interests:
Cancer cells has unique metabolic phenotype and respond differentially to various stimuli. Comprehensive understating of the epigenetic pathways that consort with metabolic reprogramming in cancer is not fully understood. We have observed that various carcinogens, metabolites and pharmaceutical inhibitors affects epigenetic reprogramming of the cancer cells. Eswara is investigating re-structuring of epigenetic and metabolic networks in prostate and bladder cancer cells and exploring reverting of onco-metabolic alterations.
Selected Publications:
- Eswara Rao Puppala, Long Wu, Xiaoxuan Fan, and Xuefang Cao. CD27 signaling inhibits tumor growth and metastasis via CD8 + T cell-independent mechanisms in the B16-F10 melanoma model. Cancer Immunology, Immunotherapy. Aug 2024
Eswara Puppala, PhD
M.Sc., Andhra Pradesh, India
PhD, National Institute of Pharmaceutical Education and Research (NIPER)
Contact:
Email: eswar@wustl.edu
Phone: 314-273-7759